New Jersey: The Second conference for Asian New Drug Development was held at Town Hall Funabori, Tokyo, Japan on May 29-30, 2008. Various topics like practical operation issues for multinational Clinical trials including Asian Countries, Project Management in Asian countries and Asian contribution for global development including operational procedures, GCP audits, drug supply management, and medical doctor contribution was discussed from both the Sponsors and Reviewers point of view.
Experts from mainland China, South Korea, Singapore, Taiwan, and other countries around the world discussed their experiences in the areas of Managing multinational clinical trials, Comparative analysis of sites/investigators among Asian countries, Development strategy; A productive dialogue with MHLW/PMDA and Asian regulators in order to develop new drugs to contribute to the Asian public health was also took place.
Mr. Mahesh Malneedi, president of MakroCare represented The Asian New Drug Development Conference held at Town Hall Funabori, Tokyo, Japan on May 29-30, 2008. He said, ” the Annual Conference has covered important areas in Biotechnology, research, development, and market trend, Business opportunities in Asian Countries and many more new areas addressed to global business needs “.
The 2nd Annual Conference for ASIAN NEW DRUG DEVELOPMENT has attracted more industry leaders and professionals, including Clinical development professionals, Personnel involved in regulatory affairs, Personnel at clinical study sites, and Personnel at CROs and SMOs represented from around the world particularly Asian Countries.
MakroCare,a global clinical services firm, provides clinical research support to pharmaceutical, biotechnology, and medical device industries. The company offers site selection, patient recruitment, project and data management, clinical monitoring, quality assurance, medical writing, PMS/PharmacoVigilance, biometrics, and regulatory assistance. MakroCare has offices in USA (New Jersey, Illinois, Pennsylvania), Europe(Frankfurt, Germany) and India (Hyderabad)